Ninth Circuit Remands Royalty Dispute Over Zilactin
A federal appeals court has ruled that a lower court overstepped its bounds by determining that an agreement over royalties for a patent covering a herpes treatment was unenforceable....To view the full article, register now.
Already a subscriber? Click here to view full article